What are the ethical aspects of the decisions on substitution and their reversibility?;Quels sont les aspects éthiques des décisions de suppléance et de leur réversibilité?

Revue Neurologique

Volumn 162, Issue HS2, 2006, Pages

  Guerrier, M ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CONFERENCE PAPER; DEONTOLOGY; FLUID THERAPY; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; MORTALITY; NUTRITION; RESPIRATION DEPRESSION; SEDATION; TRACHEOSTOMY;

EID: 33749675461     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. ANAES (2002). Modalités de prise en charge de l'adulte nécessitant des soins palliatifs, Recommandations et réfé rences professionnelles.
2. BALL L, et al. (2004). Acceptance au augmentative and alternative communication technology by persons with amyotrophic lateral sclerosis. Augmentative and alternative communication, 20: 113-122.
3. BENDIT J. (2000). Noninvasive ventilation at the end of life. Respiratory Care, 45: 1376-1381.
4. BERNAT JL. (1994). Ethical Theory, in Ethical issues in neurology, Butterworth-Heinemann, Boston: 10-16.
5. BOLMSJÖ I, HERMERÉN G. (2003). Conflicts if Interests: experiences of close relatives of patients suffering from amyotrophic lateral sclerosis. Nursing Ethics, 10: 186-198.
6. BORASIO G, VOLTZ R. (1998). Discontinuation of mechanical ventilation in patients with amyotrophic lateral sclerosis. Journal of neurology, 245: 717-722.
7. BOURKE S, GIBSON G. (2004). Non-invasive ventilation in ALS: current practice and future role. ALS and other motor neuron disorders, 5: 67-71.
8. BRODY H. (1997). Withdrawing Intensive Life-Sustaining Treatment - Recommendations for the compassionate clinical management. New England Journal of medicine, 336: 652-657.
9. CARROLL-THOMAS S. (1993). Ethics and the clinician: the daily experience with motor neurone disease. Palliative medicine, 7: 11-13.
10. CARVER AC, et al. (1999). End-of-life care: a survey of US neurologist's attitudes, behavior and knowledge. Neurology, 53: 284-294.
11. CAZZOLI P, OPPENHEIMER E. (1996). Home mechanical ventilation for amyotrophic lateral sclerosis: nasal compared to tracheostomy-intermittent positive pressure ventilation. Journal of the neurological sciences, 139: 123-128.
12. CHERNY NI, PORTENOY RK. (1994). Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care, 10: 31-38.
13. Code de la Santé Publique, France, Art. L1110-2 et suivants.
14. Code de la santé Publique, France, Art. R4127-35 à R4127-38.
15. Council of the association of british neurologists. (1999). Guidelines for the management of motor neuron disease. Excerpta medica MND advisory group.
16. DALY BJ, et al. (1993). Withdrawal of mechanical ventilation: ethical principles and guidelines for terminal weaning. Al Crit Care, 2: 217-223.
17. EBERHARDIE C. (2002). Nutrition support in palliative care. Nursing standard, 17: 47-52.
18. GANZINI L, JOHNSTON W, SILVEIRA M. (2002). The final month of life in patients with ALS. Neurology, 59: 428-431.
19. GILLICK M. (2004). Terminal sedation: an acceptable exit strategy? Annals of internal medicine, 3: 236-327.
20. GOLDBLATT D, GREENLAW J. (1989). Starting and stopping the ventilator for patients with amyotrophic lateral sclerosis. Neurologic Clinics, 7: 789-806.
21. HARLOS M. "Clinical case 2: ventilator withdrawal of patients with 'zero capacity' for respiratory function", http://www.amaassn.org/ama/pub/ category/9419.html (accessible le 28 juin 2005).
22. HAYASHI H. (1997). Ventilatory support: Japanese experience. Journal of Neurological Sciences, 152: S97-100.
23. JANSEN L, SULMASY D. (2002). Sedation, alimentation, hydration and equivocatio: careful conversation about care at the end of life. Ann Intern Med, 135: 845-849.
24. KAUB-WITTEMER, et al. (2003). Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. Journal of pain and symptom management, 26: 890-893.
25. KENT MA. (1996). The ethical arguments concerning the artificial ventilation of patients with motor neurone disease. Nursing Ethics, 3: 317-328.
26. KNOBLAUCH A, GUGGER M, KELLER R, et al. (2001). Forum Med suisse, 39: 972-978.
27. KRAKAUER EL, PENSON RT, TRUOG RD, KING LA, CHABNER BA, LYNCH TJ Jr. (2000). Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effect. Oncologist, 5: 53-62.
28. MILLER FG, MEIER DE. (1998). Voluntary death: a comparison of terminal dehydration and physician-assisted suicide. Ann Intern Med, 128: 559-562.
29. MILLER RG, et al. (1999). Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review). Report of the quality Standards Subcommittee of the American Academy of Neurology. Neurology, 52: 1311-1323.
30. MOSS A. (1996). Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation, advanced care planning and outcomes. Chest, 110: 249-255.
31. MOSS AH, et al. (1993). Home Ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology, 43: 438-443.
32. NEUDERT C, et al. (2001). The course of the terminal phase in patients with amyotrophic lateral sclerosis. Journal of neurology, 248: 612-616.
33. OLIVER D. (2004). Ventilation in motor neuron disease: difficult decisions in difficults circumstances. ALS and other motor neuron disorders, 5: 6-8.
34. POLKEY M, et al. (1999). Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease. Thorax, 54: 367-371.
35. Propositions politiques à la Commission Européenne par les Partenaires du Projet BIOMED-II, projet sur les Principes Éthiques de Base en Bioéthique et Biodroit. Publiés dans : Basic ethical principles in European bioethics and biolaw, Centre for ethics and law, Copenhagen, Institut Borja de Bioethica, Barcelona, 2000.
36. QUILL T, DRESSER R, BROCK D. (1997). The rule of double effect - A critique of its role in end-of-life decision making. New England Journal of Medicine, 337: 1768-1771.
37. QUINN WS. (1989). Actions, intentions, and consequences: the doctrine of double effect. Philos Public Aff, 18: 334-351.
38. Recommandations de la Société de Réanimation en Langue Française (2002). Les limitations et arrêts de thérapeutique(s) active(s) en réanimation adulte. http://www.srlf.org/download/recom.LATA.pdf
39. RIETJENS JA, et al. (2004). Physicians report of terminal sedation without hydration or nutrition for patient nearing death in the Netherland. Annals of internal medicine, 141: 178-185.
40. ROUSSEAU P. (1996). Terminal sedation in the care of dying patients. Arch Intern Med, 156: 1785-1786.
41. ROWLAND L. (1998). Assisted suicide and alternatives in amyotrophic lateral sclerosis. New England Journal of Medicine, 339: 987-989.
42. RUSSEL J. (1998). Ethical consideration in disease management of amyotrophic lateral sclerosis: a cross-cultural, worldwide perspective. Journal of Neurology, 245: S4-S6.
43. SCHARZ J, DEL BENE M. (2004). Withdrawing ventilator support for a home-based amyotrophic lateral sclerosis patient: a case study. Journal of clinical ethics, 15: 282-290.
44. SILVERSTEIN, et al. (1991). Amyotrophic lateral sclerosis and life-sustaining therapy: patient's desire for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc, 66: 906-913.
45. SONIES B. (2000). Patterns of care for dysphagic patients with degenerative neurological diseases. Seminars in speech and language, 21: 333-345.
46. TANDAN R, BRADLEY WG. (1985). Amyotrophic Lateral Sclerosis: Part 1. Clinical Features, Pathology, and Ethical Issues in Management. Annals of Neurology, 18: 271-280.